4 Players Join Plasma Alliance to Develop Unbranded Immunoglobulin for COVID-19, Global Study Slated for This Summer

May 11, 2020
The CoVIg-19 Plasma Alliance, a plasma industry collaboration recently launched for the development of a plasma-derived hyperimmune globulin therapy for COVID-19, has expanded its list of membership from 6 to 10, partners said on May 7. They aim for the...read more